HURA
TuHURA Biosciences, Inc.
Price Chart
Latest Quote
$2.52
-0.12 (-4.55%)
Current Price
| Previous Close | $2.64 |
| Open | $2.58 |
| Day High | $2.70 |
| Day Low | $2.45 |
| Volume | 420,182 |
Stock Information
| Shares Outstanding | 63.68M |
| Total Debt | $457K |
| Cash Equivalents | $6.30M |
| Net Income | $-30.93M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $160.48M |
| EPS (TTM) | $-0.61 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $155.24M |
| Income | $-30.93M |
| Book/sh | $0.36 |
| Cash/sh | $0.10 |
| Employees | 22 |
Financial Ratios
| Quick Ratio | 1.07 |
| Current Ratio | 1.15 |
| Debt/Eq | 1.97 |
Returns & Margins
| ROA | -81.88% |
| ROE | -187.16% |
Ownership
| Insider Ownership | 34.65% |
| Institutional Ownership | 14.97% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -4.34 |
| P/B | 7.00 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $8.04 |
Technical Indicators
| SMA20 | $2.28 |
| SMA50 | $2.40 |
| SMA200 | $1.87 |
| RSI | 63.51 |
| ATR | 0.2051 |
| Shares Float | 35.59M |
| Short Float | 17.19% |
| Short Ratio | 14.69 |
| Rel Volume | 0.80 |
Performance History
| Week | +13.00% |
| Month | +0.80% |
| Quarter | +27.92% |
| 6 Months | +207.69% |
| YTD | +236.00% |
| Year | -0.40% |
| 3 Years | -97.99% |
| 5 Years | -99.92% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $2.52 | 420,182 |
| 2026-06-23 | $2.64 | 815,000 |
| 2026-06-22 | $2.71 | 782,100 |
| 2026-06-18 | $2.57 | 1,096,300 |
| 2026-06-17 | $2.22 | 493,100 |
| 2026-06-16 | $2.23 | 323,600 |
| 2026-06-15 | $2.27 | 782,500 |
| 2026-06-12 | $2.32 | 436,700 |
| 2026-06-11 | $2.19 | 198,400 |
| 2026-06-10 | $2.08 | 417,800 |
| 2026-06-09 | $2.02 | 390,900 |
| 2026-06-08 | $2.05 | 442,900 |
| 2026-06-05 | $1.97 | 1,068,500 |
| 2026-06-04 | $2.19 | 297,700 |
| 2026-06-03 | $2.12 | 490,000 |
| 2026-06-02 | $2.18 | 300,500 |
| 2026-06-01 | $2.24 | 368,200 |
| 2026-05-29 | $2.26 | 468,700 |
| 2026-05-28 | $2.35 | 413,300 |
| 2026-05-27 | $2.38 | 509,400 |
| 2026-05-26 | $2.45 | 518,900 |
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
đ° Latest News
Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money?
Insider Monkey âĸ 2026-04-20T14:14:38Z
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit
Simply Wall St. âĸ 2026-04-02T10:13:05Z
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) last week's 11% decline must have disappointed retail investors who have a significant stake
Simply Wall St. âĸ 2025-08-11T10:11:07Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $625,283 | $4,138,301 | $18,688 | $0 |
| Total Expenses | $27,289,239 | $17,151,525 | $13,170,156 | $9,718,934 |
| Other Income Expense | $-2,273,688 | $-754,112 | $-16,217,655 | $294,070 |
| Net Non Operating Interest Income Expense | $-489,050 | $-3,776,669 | $70,985 | $57,351 |
| Interest Expense Non Operating | $625,283 | $4,138,301 | $18,688 | $0 |
| Operating Expense | $27,289,239 | $17,151,525 | $13,170,156 | $9,718,934 |
| Other Operating Expenses | $-713,508 | $-57,627 | $-42,466 | $-214,917 |
| General And Administrative Expense | $7,583,651 | $3,873,836 | $4,144,648 | $2,005,282 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Net Interest Income | $-489,050 | $-3,776,669 | $70,985 | $57,351 |
| Interest Income | $136,233 | $361,632 | $89,673 | $57,351 |
| Normalized Income | $-27,778,516 | $-20,928,345 | $-13,099,171 | $-9,661,583 |
| Net Income From Continuing And Discontinued Operation | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Total Operating Income As Reported | $-31,795,939 | $-17,649,492 | $-29,764,720 | $-9,933,851 |
| Net Income Common Stockholders | $-30,060,333 | $-22,649,572 | $-29,316,826 | $-9,367,513 |
| Net Income | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Net Income Including Noncontrolling Interests | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Net Income Continuous Operations | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Pretax Income | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Special Income Charges | $-3,864,637 | $-440,340 | $-16,217,655 | $294,070 |
| Interest Income Non Operating | $136,233 | $361,632 | $89,673 | $57,351 |
| Operating Income | $-27,289,239 | $-17,151,525 | $-13,170,156 | $-9,718,934 |
| Per Share | ||||
| Diluted EPS | $-0.63 | $-1.21 | $-2.47 | $-0.77 |
| Basic EPS | $-0.63 | $-1.21 | $-2.47 | $-0.77 |
| Other | ||||
| Tax Effect Of Unusual Items | $-227 | $-151 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-27,081,741 | $-16,673,183 | $-12,903,106 | $-9,288,490 |
| Total Unusual Items | $-2,273,688 | $-754,112 | $-16,217,655 | $294,070 |
| Total Unusual Items Excluding Goodwill | $-2,273,688 | $-754,112 | $-16,217,655 | $294,070 |
| Reconciled Depreciation | $71,265 | $116,710 | $177,377 | $373,093 |
| EBITDA (Bullshit earnings) | $-29,355,429 | $-17,427,295 | $-29,120,761 | $-8,994,420 |
| EBIT | $-29,426,694 | $-17,544,005 | $-29,298,138 | $-9,367,513 |
| Diluted Average Shares | $47,927,196 | $18,662,690 | $11,889,193 | $12,176,127 |
| Basic Average Shares | $47,927,196 | $18,662,690 | $11,889,193 | $12,176,127 |
| Diluted NI Availto Com Stockholders | $-30,060,333 | $-22,649,572 | $-29,316,826 | $-9,367,513 |
| Otherunder Preferred Stock Dividend | $0 | $965,177 | $0 | - |
| Preferred Stock Dividends | $8,356 | $2,089 | - | - |
| Other Special Charges | $3,679,618 | $440,340 | $16,217,655 | $-294,070 |
| Restructuring And Mergern Acquisition | $185,019 | $0 | - | - |
| Gain On Sale Of Security | $1,590,949 | $-313,772 | - | - |
| Other Taxes | $-113,574 | $0 | $-334,443 | $0 |
| Research And Development | $20,532,670 | $13,335,316 | $9,402,417 | $7,928,569 |
| Selling General And Administration | $7,583,651 | $3,873,836 | $4,144,648 | $2,005,282 |
| Other Gand A | $7,583,651 | $3,873,836 | $4,144,648 | $2,005,282 |
| Write Off | - | - | - | $0 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,080,754 | $14,593,976 | $-1,558,746 | $12,303,941 |
| Total Assets | $27,353,156 | $19,966,684 | $4,361,791 | $15,196,608 |
| Total Non Current Assets | $22,732,020 | $356,295 | $202,990 | $452,316 |
| Other Non Current Assets | $33,769 | $33,769 | - | $33,769 |
| Goodwill And Other Intangible Assets | $22,013,082 | $0 | - | - |
| Other Intangible Assets | $11,275,000 | - | - | - |
| Current Assets | $4,621,136 | $19,610,389 | $4,158,801 | $14,744,292 |
| Other Current Assets | $333,526 | $316,352 | $159,326 | $491,774 |
| Prepaid Assets | $167,661 | $6,199,458 | $0 | - |
| Receivables | $500,000 | $437,401 | $334,443 | $101,424 |
| Other Receivables | $500,000 | $222,702 | - | - |
| Taxes Receivable | $0 | $214,699 | $334,443 | - |
| Cash Cash Equivalents And Short Term Investments | $3,619,949 | $12,657,178 | $3,665,032 | $14,252,518 |
| Cash And Cash Equivalents | $3,619,949 | $12,657,178 | $3,665,032 | $14,252,518 |
| Accrued Interest Receivable | - | - | $101,424 | $1,424 |
| Notes Receivable | - | - | $100,000 | $100,000 |
| Debt | ||||
| Total Debt | $700,022 | $202,542 | $2,344,978 | $138,224 |
| Long Term Debt And Capital Lease Obligation | $303,627 | $42,698 | $2,324,158 | $20,743 |
| Current Debt And Capital Lease Obligation | $396,395 | $159,844 | $20,820 | $117,481 |
| Current Debt | $197,354 | - | - | - |
| Long Term Debt | - | - | $2,324,158 | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,420,828 | $5,372,708 | $5,920,537 | $2,892,667 |
| Total Non Current Liabilities Net Minority Interest | $501,546 | $42,698 | $2,324,158 | $20,743 |
| Non Current Deferred Liabilities | $197,919 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $197,919 | $0 | - | - |
| Current Liabilities | $5,919,282 | $5,330,010 | $3,596,379 | $2,871,924 |
| Current Notes Payable | $197,354 | $0 | - | $0 |
| Payables And Accrued Expenses | $3,997,748 | $4,008,516 | $2,023,162 | $2,079,443 |
| Payables | $3,770,124 | $3,152,816 | $1,866,762 | $1,915,766 |
| Accounts Payable | $3,770,124 | $3,152,816 | $1,866,762 | $1,915,766 |
| Other Current Liabilities | - | - | $137,000 | - |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $20,653,798 | $14,315,446 | $-1,575,659 | $12,295,879 |
| Preferred Stock Equity | $278,530 | $278,530 | $16,913 | $8,062 |
| Total Equity Gross Minority Interest | $20,932,328 | $14,593,976 | $-1,558,746 | $12,303,941 |
| Stockholders Equity | $20,932,328 | $14,593,976 | $-1,558,746 | $12,303,941 |
| Retained Earnings | $-141,184,902 | $-111,124,569 | $-88,474,997 | $-59,158,171 |
| Other | ||||
| Ordinary Shares Number | $59,336,104 | $42,323,759 | $42,030,336 | $42,030,336 |
| Share Issued | $59,336,104 | $42,323,759 | $42,030,336 | $42,030,336 |
| Tangible Book Value | $-1,359,284 | $14,315,446 | $-1,575,659 | $12,295,879 |
| Invested Capital | $20,851,152 | $14,315,446 | $748,499 | $12,295,879 |
| Working Capital | $-1,298,146 | $14,280,379 | $562,422 | $11,872,368 |
| Capital Lease Obligations | $502,668 | $202,542 | $20,820 | $138,224 |
| Total Capitalization | $20,932,328 | $14,593,976 | $765,412 | $12,303,941 |
| Additional Paid In Capital | $161,779,364 | $125,397,691 | $86,887,170 | $71,449,521 |
| Capital Stock | $337,866 | $320,854 | $29,081 | $12,591 |
| Common Stock | $59,336 | $42,324 | $12,168 | $4,529 |
| Preferred Stock | $278,530 | $278,530 | $16,913 | $8,062 |
| Long Term Capital Lease Obligation | $303,627 | $42,698 | $0 | $20,743 |
| Current Capital Lease Obligation | $199,041 | $159,844 | $20,820 | $117,481 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,525,139 | $1,161,650 | $1,415,397 | $675,000 |
| Current Accrued Expenses | $227,624 | $855,700 | $156,400 | $163,677 |
| Goodwill | $10,738,082 | $0 | - | - |
| Net PPE | $685,169 | $322,526 | $202,990 | $418,547 |
| Accumulated Depreciation | $-2,158,712 | $-2,087,447 | $-1,970,736 | $-1,793,359 |
| Gross PPE | $2,843,881 | $2,409,973 | $2,173,726 | $2,211,906 |
| Leases | $544,629 | $544,629 | $544,628 | $544,628 |
| Other Properties | $384,530 | $199,160 | $20,820 | $138,224 |
| Machinery Furniture Equipment | $1,914,722 | $1,666,184 | $1,608,278 | $1,529,054 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-27,705,233 | $-14,786,044 | $-12,030,080 | $-7,544,536 |
| Operating Activities | ||||
| Operating Cash Flow | $-27,629,150 | $-14,728,138 | $-11,950,856 | $-7,508,259 |
| Cash Flow From Continuing Operating Activities | $-27,629,150 | $-14,728,138 | $-11,950,856 | $-7,508,259 |
| Operating Gains Losses | - | $313,772 | - | $-294,070 |
| Investing Activities | ||||
| Capital Expenditure | $-76,083 | $-57,906 | $-79,224 | $-36,277 |
| Investing Cash Flow | $-1,335,361 | $-6,052,409 | $-1,296,879 | $-36,277 |
| Cash Flow From Continuing Investing Activities | $-1,335,361 | $-6,052,409 | $-1,296,879 | $-36,277 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $18,303,312 | $5,000,000 | $0 | $16,601,000 |
| Financing Cash Flow | $19,927,282 | $29,772,693 | $2,660,249 | $16,251,000 |
| Cash Flow From Continuing Financing Activities | $19,927,282 | $29,772,693 | $2,660,249 | $16,251,000 |
| Net Other Financing Charges | $-2,605,307 | $-5,844,072 | - | - |
| Cash Dividends Paid | $-8,356 | $0 | - | - |
| Preferred Stock Dividend Paid | $-8,356 | $0 | - | - |
| Net Common Stock Issuance | $18,303,312 | $5,000,000 | $-24,751 | $0 |
| Common Stock Issuance | $18,303,312 | $5,000,000 | $0 | $0 |
| Repurchase Of Capital Stock | - | $0 | $-24,751 | $0 |
| Net Preferred Stock Issuance | - | - | $0 | $16,601,000 |
| Preferred Stock Issuance | - | - | $0 | $16,601,000 |
| Other | ||||
| Repayment Of Debt | $-2,383,024 | $0 | $0 | $-350,000 |
| Issuance Of Debt | $3,000,000 | $28,568,000 | $2,685,000 | $0 |
| Interest Paid Supplemental Data | $59,364 | $0 | - | - |
| End Cash Position | $3,619,949 | $12,657,178 | $3,665,032 | $14,252,518 |
| Beginning Cash Position | $12,657,178 | $3,665,032 | $14,252,518 | $5,546,054 |
| Changes In Cash | $-9,037,229 | $8,992,146 | $-10,587,486 | $8,706,464 |
| Proceeds From Stock Option Exercised | $3,620,657 | $2,048,765 | $0 | - |
| Net Issuance Payments Of Debt | $616,976 | $28,568,000 | $2,685,000 | $-350,000 |
| Net Long Term Debt Issuance | $616,976 | $28,568,000 | $2,685,000 | $0 |
| Long Term Debt Payments | $-2,383,024 | $0 | - | - |
| Long Term Debt Issuance | $3,000,000 | $28,568,000 | $2,685,000 | $0 |
| Net Business Purchase And Sale | $-1,259,278 | $-5,994,503 | $-1,217,655 | $0 |
| Purchase Of Business | $-1,259,278 | $-5,994,503 | $-1,217,655 | $0 |
| Net PPE Purchase And Sale | $-76,083 | $-57,906 | $-79,224 | $-36,277 |
| Purchase Of PPE | $-76,083 | $-57,906 | $-79,224 | $-36,277 |
| Change In Working Capital | $-3,148,663 | $3,286,599 | $486,924 | $1,561,956 |
| Change In Other Current Assets | $612,521 | $-358,325 | $149,178 | $-286,513 |
| Change In Payables And Accrued Expense | $-3,761,184 | $3,644,924 | $337,746 | $1,848,469 |
| Other Non Cash Items | $666,443 | $1,278,424 | $5,124 | - |
| Stock Based Compensation | $6,424,730 | $1,958,663 | $478,890 | $218,275 |
| Unrealized Gain Loss On Investment Securities | $-1,590,948 | $0 | - | - |
| Depreciation Amortization Depletion | $71,265 | $116,710 | $177,377 | $373,093 |
| Depreciation And Amortization | $71,265 | $116,710 | $177,377 | $373,093 |
| Net Income From Continuing Operations | $-30,051,977 | $-21,682,306 | $-29,316,826 | $-9,367,513 |
| Common Stock Payments | - | $0 | $-24,751 | $0 |
| Asset Impairment Charge | - | $0 | $16,217,655 | $0 |
| Gain Loss On Investment Securities | - | $313,772 | - | - |
| Net Short Term Debt Issuance | - | - | $0 | $-350,000 |
| Short Term Debt Payments | - | - | $0 | $-350,000 |
| Short Term Debt Issuance | - | - | - | $0 |
| Change In Other Current Liabilities | - | - | - | $70,133 |
| Change In Other Working Capital | - | - | - | - |
Fetched: 2026-06-17